Acceleron Pharma reported $-69470000 in EBITDA for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acceleron Pharma XLRN:US $ -69.47M 6.84M
Akebia Therapeutics AKBA:US $ -45.4M 24.43M
Alexion Pharmaceuticals ALXN:US $ 892.3M 186.4M
Amgen AMGN:US $ 3228M 40M
Arena Pharmaceuticals ARNA:US $ -123.51M 19.9M
Bayer BAYN:GR € 2089M 946M
Biomarin Pharmaceutical BMRN:US $ -9.16M 48.05M
Bluebird Bio BLUE:US $ -190.8M 44.05M
Clovis Oncology CLVS:US $ -52.17M 0.97M
Dicerna Pharmaceuticals DRNA:US $ -18.82M 19.76M
Eli Lilly And LLY:US $ 2437.5M 639.8M
Exelixis EXEL:US $ 56.42M 70.25M
Gilead Sciences GILD:US $ 4370M 1605M
GlaxoSmithKline GSK:LN 3660M 1034M
Johnson & Johnson JNJ:US $ 8192M 2043M
Karyopharm Therapeutics KPTI:US $ -43626000 5.19M
Mirati Therapeutics MRTX:US $ -78.98M 84.79M
Neurocrine Biosciences NBIX:US $ 47.3M 23.1M
Novartis NOVN:VX SF 4837M 65M
Pfizer PFE:US $ 10235M 2245M
Ptc Therapeutics PTCT:US $ -76.33M 7.18M
Puma Biotechnology PBYI:US $ -6.51M 7.18M
Regeneron Pharmaceuticals REGN:US $ 1920.4M 1497.9M
Rigel Pharmaceuticals RIGL:US $ -19.52M 6.73M
Sangamo Biosciences SGMO:US $ -45.88M 0.57M
Ultragenyx Pharmaceutical RARE:US $ -86.61M 6.96M
United Therapeutics UTHR:US $ 242.3M 7.7M
Vertex Pharmaceuticals VRTX:US $ 1087.41M 1092.53M